(5-261) Content Analysis of Food and Drug Administration (FDA) Warning Letters Issued March 2020-September 2023 for Products with Fraudulent COVID-19 Prevention and Treatment Claims
Monday, December 4, 2023
4:15 PM – 5:15 PM
Location: Hall E, Lower Level
Co-Author(s): Damary Urena, Jagannath Muzumdar, Taehwan Park
